OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Trofinetide for Rett Syndrome: Highlights on the Development and Related Inventions of the First USFDA-Approved Treatment for Rare Pediatric Unmet Medical Need
Shuaibu Abdullahi Hudu, Fayig El-Migdadi, Aiman Al-Qtaitat, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 15, pp. 5114-5114
Open Access | Times Cited: 16
Shuaibu Abdullahi Hudu, Fayig El-Migdadi, Aiman Al-Qtaitat, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 15, pp. 5114-5114
Open Access | Times Cited: 16
Showing 16 citing articles:
Pharmacological Aspects in the Management of Children and Adolescents with Prader–Willi Syndrome
Jennifer Miller, Shivani Berry, Esraa Ismail
Pediatric Drugs (2025)
Closed Access
Jennifer Miller, Shivani Berry, Esraa Ismail
Pediatric Drugs (2025)
Closed Access
A novel approach to metabolic profiling in case models of MECP2-related disorders
Jessica A. Cooley Coleman, Bridgette A. Moffitt, William C. Bridges, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 2
Open Access
Jessica A. Cooley Coleman, Bridgette A. Moffitt, William C. Bridges, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 2
Open Access
Safety and efficacy of trofinetide in Rett syndrome: a systematic review and meta-analysis of randomized controlled trials
Abdallah Abbas, Aya Mamdouh Fayoud, Mostafa Hossam El Din Moawad, et al.
BMC Pediatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Abdallah Abbas, Aya Mamdouh Fayoud, Mostafa Hossam El Din Moawad, et al.
BMC Pediatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2023
Gizem Kaykı-Mutlu, Zinnet Şevval Aksoyalp, Leszek Wojnowski, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 5, pp. 2949-2970
Open Access | Times Cited: 2
Gizem Kaykı-Mutlu, Zinnet Şevval Aksoyalp, Leszek Wojnowski, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 5, pp. 2949-2970
Open Access | Times Cited: 2
BIOCHEMICAL AND MOLECULAR DETERMINANTS OF THE SUBCLINICAL INFLAMMATORY MECHANISMS IN RETT SYNDROME
Valeria Cordone
Archives of Biochemistry and Biophysics (2024) Vol. 757, pp. 110046-110046
Open Access | Times Cited: 2
Valeria Cordone
Archives of Biochemistry and Biophysics (2024) Vol. 757, pp. 110046-110046
Open Access | Times Cited: 2
Clinical Features and Disease Progression in Older Individuals with Rett Syndrome
Jeffrey L. Neul, Tim A. Benke, Eric D. Marsh, et al.
Genes (2024) Vol. 15, Iss. 8, pp. 1107-1107
Open Access | Times Cited: 2
Jeffrey L. Neul, Tim A. Benke, Eric D. Marsh, et al.
Genes (2024) Vol. 15, Iss. 8, pp. 1107-1107
Open Access | Times Cited: 2
Trofinetide—a new chapter in rett syndrome’s treatment
Muhammad Furqan
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Muhammad Furqan
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Profile of Trofinetide in the Treatment of Rett Syndrome: Design, Development and Potential Place in Therapy
Laura Camillo, Marco Pozzi, Pia Bernardo, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 5023-5040
Open Access | Times Cited: 1
Laura Camillo, Marco Pozzi, Pia Bernardo, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 5023-5040
Open Access | Times Cited: 1
Population Pharmacokinetics of Trofinetide in a Pediatric Population Aged 2–4 Years with Rett Syndrome
Mona Darwish, Julie Passarell, Kelly Maxwell, et al.
Advances in Therapy (2024) Vol. 42, Iss. 2, pp. 1009-1025
Open Access | Times Cited: 1
Mona Darwish, Julie Passarell, Kelly Maxwell, et al.
Advances in Therapy (2024) Vol. 42, Iss. 2, pp. 1009-1025
Open Access | Times Cited: 1
Trofinetide approved for children and adults with Rett syndrome (RTT): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)
Pavalan Selvam, Carlos F. Mares Beltrán, Kuntal Sen, et al.
Genetics in Medicine Open (2024) Vol. 2, pp. 101856-101856
Open Access
Pavalan Selvam, Carlos F. Mares Beltrán, Kuntal Sen, et al.
Genetics in Medicine Open (2024) Vol. 2, pp. 101856-101856
Open Access
Clinical Features and Disease Progression in Older Individuals With Rett Syndrome
Jeffrey L. Neul, Tim A. Benke, Eric D. Marsh, et al.
(2024)
Open Access
Jeffrey L. Neul, Tim A. Benke, Eric D. Marsh, et al.
(2024)
Open Access
Deciphering the physiopathology of neurodevelopmental disorders using brain organoids
Olivier Dionne, Salomé Sabatié, Benoît Laurent
Brain (2024)
Open Access
Olivier Dionne, Salomé Sabatié, Benoît Laurent
Brain (2024)
Open Access
Therapies that address altered gene regulation
Moyra Smith
Elsevier eBooks (2024), pp. 263-292
Closed Access
Moyra Smith
Elsevier eBooks (2024), pp. 263-292
Closed Access
The Newborn Screening Programme Revisited: An Expert Opinion on the Challenges of Rett Syndrome
Jatinder Singh, Paramala Santosh
Genes (2024) Vol. 15, Iss. 12, pp. 1570-1570
Open Access
Jatinder Singh, Paramala Santosh
Genes (2024) Vol. 15, Iss. 12, pp. 1570-1570
Open Access
Special Issue “Diagnosis and Treatment of Rare Diseases”
Á. Hermida Ameijeiras
Journal of Clinical Medicine (2024) Vol. 13, Iss. 9, pp. 2574-2574
Open Access
Á. Hermida Ameijeiras
Journal of Clinical Medicine (2024) Vol. 13, Iss. 9, pp. 2574-2574
Open Access
Improvement in symptoms of Rett syndrome with trofinetide beyond clinical trial efficacy assessments: case reports
Robin C. Ryther, Christine Palladino, Sanjeev V. Kothare
Future Rare Diseases (2024) Vol. 4, Iss. 1
Open Access
Robin C. Ryther, Christine Palladino, Sanjeev V. Kothare
Future Rare Diseases (2024) Vol. 4, Iss. 1
Open Access
